Christian International Relief group, Samaritan’s Purse, announced today that SIM nurse missionary Nancy Writebol, who contracted Ebola Virus Disease (EVD) in Liberia, has arrived in the United States.
It is reported that Writebol is in an isolation unit at Emory University Hospital in Atlanta, same as Dr. Kent Brantly, who arrived there on Saturday.
Both infected health providers are improving from the disease.
Amber Brantly, the wife of Dr. Brantly said, “I have been able to see Kent every day, and he continues to improve. I am thankful for the professionalism and kindness of Dr. Ribner and his team at Emory University Hospital. I know that Kent is receiving the very best medical treatment available.
“I am also thrilled to see that Nancy arrived safely in Atlanta today. Our families are united in our faith in Jesus, and we will walk through this recovery time together.
“Please continue to pray for Kent, Nancy, and the people of Liberia. “
Both Brantly and Writebol received the experimental monoclonal antibody, ZMapp.
ZMappTM is the result of a collaboration between Mapp Biopharmaceutical, Inc. and LeafBio (San Diego, CA), Defyrus Inc. (Toronto, Canada), the U.S. government and the Public Health Agency of Canada (PHAC).
ZMappTM is composed of three “humanized” monoclonal antibodies manufactured in plants, specifically Nicotiana. It is an optimized cocktail combining the best components of MB-003 (Mapp) and ZMAb (Defyrus/PHAC).
ZMappTM was first identified as a drug candidate in January 2014 and has not yet been evaluated for safety in humans. As such, very little of the drug is currently available.
For more infectious disease news and information, visit and “like” the Infectious Disease News Facebook page